|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.836
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.815
|
Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.686
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.632
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.628
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.612
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.611
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.610
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.601
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.577
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.556
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.526
|
Mouse |
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.519
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.482
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.474
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.469
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.464
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.458
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.455
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.437
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.427
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.414
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.410
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.405
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.397
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.395
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.393
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.391
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.386
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.377
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.377
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.366
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.356
|
|
|
|
negative regulation of axon guidance
|
GO:1902668 |
8 |
0.323
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.323
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.322
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.318
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.313
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.307
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.300
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.299
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.297
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.296
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.293
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.292
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.290
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.289
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.288
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.282
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.281
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.273
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.272
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.271
|
|
|
|
learning
|
GO:0007612 |
98 |
0.270
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.267
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.262
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.260
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.260
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.257
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.253
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.252
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.249
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.244
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.244
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.243
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.241
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.240
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.238
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.229
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.226
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.226
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.225
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.224
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.221
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.219
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.218
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.215
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.214
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.211
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.211
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.211
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.210
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.210
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.208
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.205
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.203
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.200
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.198
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.198
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.196
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.194
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.192
|
|
|
|
negative regulation of lyase activity
|
GO:0051350 |
1 |
0.191
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.191
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.189
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.188
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.188
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.186
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.180
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.177
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.176
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.174
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.174
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.173
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.173
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.171
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.170
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.169
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.169
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.168
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.168
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.168
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.167
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.166
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.166
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.165
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.165
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.163
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.163
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.161
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.161
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.160
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.157
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.157
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.157
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.156
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.155
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.154
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.153
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.153
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
13 |
0.150
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.150
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.149
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.147
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.147
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.147
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.147
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.146
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.146
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.146
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.145
|
Mouse |
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.144
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.144
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.144
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.143
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.142
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.142
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.142
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.140
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.139
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.139
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.139
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.138
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.136
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.135
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.133
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.133
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.132
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.132
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.131
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.131
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.130
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.130
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.130
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.126
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.126
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.126
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.126
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.124
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.124
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.120
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.119
|
|
|
|
regulation of lyase activity
|
GO:0051339 |
13 |
0.118
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.116
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.116
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.114
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.114
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.114
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.114
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.113
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.112
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.112
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.112
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.111
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.111
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.110
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.109
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.109
|
Mouse |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.108
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.108
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.108
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.107
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.106
|
Mouse |
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.106
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.102
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.102
|
Mouse |
|
|
neural tube development
|
GO:0021915 |
160 |
0.102
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.102
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.102
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.101
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.101
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.100
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.099
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.099
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.099
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.099
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.099
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.098
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.098
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.098
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.098
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.098
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.097
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.097
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.097
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.096
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
13 |
0.096
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.095
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.094
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.094
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.093
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.093
|
|
|
|
regulation of synaptic transmission glutamatergic
|
GO:0051966 |
19 |
0.093
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.093
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.093
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.092
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.092
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.092
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.091
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.090
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.089
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.089
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.088
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.087
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.087
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.087
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.086
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.086
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.086
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.086
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.086
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.085
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.084
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.084
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.084
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.084
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.084
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.083
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.083
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.083
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.082
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.082
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.082
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
36 |
0.082
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.082
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.082
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.081
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.081
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.080
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.080
|
|
|
|
mucosal associated lymphoid tissue development
|
GO:0048537 |
12 |
0.080
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.080
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.080
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.080
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.080
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.079
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.079
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.079
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.079
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.077
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.077
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.077
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.076
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.076
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.076
|
|
|
|
branchiomotor neuron axon guidance
|
GO:0021785 |
7 |
0.076
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.075
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.075
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.075
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.075
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.074
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.074
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.074
|
|
|
|
substrate independent telencephalic tangential migration
|
GO:0021826 |
8 |
0.073
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.073
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.073
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.073
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.073
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.073
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.073
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.073
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.073
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.072
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.072
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.072
|
|
|
|
regulation of systemic arterial blood pressure by norepinephrine epinephrine
|
GO:0001993 |
8 |
0.071
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.071
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.071
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.071
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.071
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.071
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.070
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.070
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.070
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.070
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.070
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.070
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.069
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.069
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.069
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.069
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.069
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.069
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.068
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.068
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.067
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.067
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.067
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.067
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.067
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.067
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.066
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.066
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.066
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.065
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.064
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.064
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.064
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.064
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.064
|
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.064
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.063
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.063
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.063
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.063
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.062
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.062
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.062
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.061
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.061
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.061
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.061
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.061
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.060
|
|
|
|
semaphorin plexin signaling pathway involved in bone trabecula morphogenesis
|
GO:1900220 |
2 |
0.060
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.060
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.060
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.060
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.060
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.060
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.059
|
|
|
|
grooming behavior
|
GO:0007625 |
16 |
0.059
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.059
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.059
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.059
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.058
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.058
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.058
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.058
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.057
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.057
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.057
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.057
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.057
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.057
|
|
|
|
substrate independent telencephalic tangential interneuron migration
|
GO:0021843 |
8 |
0.057
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.057
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.057
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.056
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.056
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.056
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.055
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.055
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.055
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
22 |
0.055
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.055
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.054
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.054
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.054
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.054
|
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.054
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.053
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.053
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.053
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
13 |
0.053
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.053
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.053
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.053
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.052
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.052
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.052
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.052
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.052
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.052
|
|
|
|
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0072108 |
3 |
0.052
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.052
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.052
|
|
|
|
regulation of long term neuronal synaptic plasticity
|
GO:0048169 |
19 |
0.051
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.051
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.051
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.051
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.051
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.051
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.050
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.050
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.050
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.050
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.050
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.050
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.050
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.050
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.050
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.049
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.049
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.049
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.049
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.049
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.049
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.049
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.049
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.048
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.048
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.048
|
|
|
|
general adaptation syndrome behavioral process
|
GO:0051867 |
1 |
0.048
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.048
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.048
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.048
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.048
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.047
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.047
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.047
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.047
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.047
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.047
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.047
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.047
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.047
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.047
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.047
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.046
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.046
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.046
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.046
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.046
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.046
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.046
|
|
|
|
optic nerve development
|
GO:0021554 |
8 |
0.045
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.045
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.045
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.045
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.045
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.045
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.045
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.045
|
|
|
|
regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010578 |
3 |
0.045
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.045
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.045
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.045
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.044
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.044
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.044
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.044
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.044
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.044
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.044
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.044
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.044
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.044
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.044
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.044
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.044
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.044
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.044
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.043
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.043
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.043
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.043
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.043
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.043
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
10 |
0.043
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.043
|
|
|
|
regulation of corticosterone secretion
|
GO:2000852 |
2 |
0.043
|
|
|
|
positive regulation of synaptic transmission glutamatergic
|
GO:0051968 |
8 |
0.043
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.042
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.042
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.042
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.042
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.042
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.042
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.042
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.042
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.041
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.041
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.041
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.041
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.041
|
|
